Tonix Pharmaceuticals logo

Tonix Pharmaceuticals

Manager, SEC Reporting at Tonix Pharmaceuticals

Berkeley Heights, NJFull-timeFinancePosted about 2 months ago
Apply with Pipeline

About the Role

<div class="content-intro"><div> <p class="x_MsoNormal"><span style="font-family: helvetica, arial, sans-serif; font-size: 12pt;"><span data-olk-copy-source="MessageBody">Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix’s CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti-<em>Borrelia</em>&nbsp;OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit&nbsp;</span><a href="https://nam10.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.globenewswire.com%2FTracker%3Fdata%3D9p5FBvlzG2u-9NzVEDdUgRNdl57Mw08p4h9XviYYnbwVJ-X_DNEOeN4RdGA64IhTnk9R4lQWNXhq0g8TrvoRTCZSpqmowBapMZCbqP_sxm0%3D&amp;data=05%7C02%7Cmarsha.ihrig%40tonixpharma.com%7C016ba434378242bb501908dea48d8908%7C9f3c9f8851ca4393815e405a5f206a29%7C0%7C0%7C639129124987080441%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&amp;sdata=WrmW8ZuY9XRYJZM0BMPu3thoab5uVHnt9SqBNHIoDuU%3D&amp;reserved=0" data-auth="NotApplicable" data-linkindex="11">www.tonixpharma.com</a>&nbsp;and follow the Company on&nbsp;<a href="https://nam10.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.globenewswire.com%2FTracker%3Fdata%3DbldblPUeLBo2VtrimIDsthVk4RaPH1sCjnDw18J2Q9UGKOYpi7kKsd6NuJ4rb7a1ocGevguAt4l_8t8TE5rfCP1YmSBTJO1HR9Uo9KAv_DEwtbEkJhm1CdLRAEbAUNB-&amp;data=05%7C02%7Cmarsha.ihrig%40tonixpharma.com%7C016ba434378242bb501908dea48d8908%7C9f3c9f8851ca4393815e405a5f206a29%7C0%7C0%7C639129124987109283%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&amp;sdata=dHRzyv5dfKFOhCroh809txjNcJOjNrBSQRyfSgHaIu8%3D&amp;reserved=0" data-auth="NotApplicable" data-linkindex="12">LinkedIn</a>&nbsp;and&nbsp;<a href="https://nam10.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.globenewswire.com%2FTracker%3Fdata%3D0NgIEJjy96AytWlfgCqgqVv5cOeUVkGOTFS78koSy22XXOczOtXjxSorNUcN-uDTk4CYVQkJndgCk6o2RQBlKQ%3D%3D&amp;data=05%7C02%7Cmarsha.ihrig%40tonixpharma.com%7C016ba434378242bb501908dea48d8908%7C9f3c9f8851ca4393815e405a5f206a29%7C0%7C0%7C639129124987130654%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&amp;sdata=frLcoK5ETOWzJq9lmvkirCS8HaHc2WCX%2Fg4ESMSdLgk%3D&amp;reserved=0" data-auth="NotApplicable" data-linkindex="13">X</a>.</span></p> </div> <div> <p class="x_MsoNormal"><span style="font-family: helvetica, arial, sans-serif; font-size: 12pt;"><em>*Tonix’s product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication.</em></span></p> </div> <div> <p class="x_MsoNormal"><span style="font-family: helvetica, arial, sans-serif; font-size: 12pt;">Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners.</span></p> </div></div><p><span style="font-size: 12pt;"><strong>Position Overview</strong></span></p> <p><span style="font-size: 12pt;">Tonix Pharmaceuticals is seeking an experienced Manager, Financial Reporting to lead and manage the Company's external financial reporting process and SEC compliance activities. This role will be responsible for preparing and reviewing SEC filings, maintaining technical accounting documentation, supporting ad hoc reporting and analysis, and partnering cross-functionally with finance, legal, investor relations, and external auditors. The ideal candidate possesses deep SEC reporting expertise, strong technical accounting knowledge, and prior Big Four public accounting experience.</span></p> <p><span style="font-size: 12pt;"><strong>Key Responsibilities</strong></span></p> <ul> <li style="font-size: 12pt;"><span style="font-size: 12pt;">Lead the preparation, review, and timely filing of all SEC reports, including Forms 10-K, 10-Q, 8-K, Proxy Statements, Section 16 filings, and other required disclosures.</span></li> <li style="font-size: 12pt;"><span style="font-size: 12pt;">Prepare and maintain SEC reporting support schedules, disclosure checklists, and reporting calendars.</span></li> <li style="font-size: 12pt;"><span style="font-size: 12pt;">Draft, update, and maintain technical accounting memos documenting the Company's accounting positions and conclusions under U.S. GAAP and SEC regulations.</span></li> <li style="font-size: 12pt;"><span style="font-size: 12pt;">Research and evaluate complex accounting issues, new accounting standards, and SEC reporting requirements and write technical memos.</span></li> <li style="font-size: 12pt;"><span style="font-size: 12pt;">Coordinate information gathering and review processes with internal stakeholders and external auditors.</span></li> <li style="font-size: 12pt;"><span style="font-size: 12pt;">Manage XBRL tagging review and support SEC filing submissions.</span></li> <li style="font-size: 12pt;"><span style="font-size: 12pt;">Assist with quarterly earnings support materials and investor reporting requirements.</span></li> <li style="font-size: 12pt;"><span style="font-size: 12pt;">Support the annual audit and quarterly review processes, including preparation of auditor deliverables.</span></li> <li style="font-size: 12pt;"><span style="font-size: 12pt;">Prepare ad hoc financial analyses, board reporting materials, and management presentations.</span></li> <li style="font-size: 12pt;"><span style="font-size: 12pt;">Support SOX compliance activities and internal control documentation related to financial reporting.</span></li> <li style="font-size: 12pt;"><span style="font-size: 12pt;">Monitor emerging accounting and SEC developments and assess potential impacts to the Company.</span></li> <li style="font-size: 12pt;"><span style="font-size: 12pt;">Drive process improvements to enhance reporting accuracy, efficiency, and compliance.</span></li> </ul> <p><span style="font-size: 12pt;"><strong>Qualifications</strong></span></p> <p>&nbsp;</p> <ul> <li style="font-size: 12pt;"><span style="font-size: 12pt;">Bachelor’s degree in Accounting or Finance required; Master’s degree preferred.</span></li> <li style="font-size: 12pt;"><span style="font-size: 12pt;">Active Certified Public Accountant (CPA) license required.</span></li> <li style="font-size: 12pt;"><span style="font-size: 12pt;">Advanced Microsoft Excel skills and proficiency with SEC reporting tools.</span></li> <li style="font-size: 12pt;"><span style="font-size: 12pt;">Excellent written and verbal communication skills with strong attention to detail.</span></li> <li style="font-size: 12pt;"><span style="font-size: 12pt;">Ability to manage multiple deadlines in a fast-paced public company environment.</span></li> <li style="font-size: 12pt;"><span style="font-size: 12pt;">Strong knowledge of U.S. GAAP, SEC regulations, and public company reporting requirements</span></li> <li style="font-size: 12pt;"><span style="font-size: 12pt;">5+ years of progressive accounting and financial reporting experience.</span></li> <li style="font-size: 12pt;"><span style="font-size: 12pt;">Minimum 3–5 years of direct SEC reporting experience with responsibility for Forms 10-K, 10-Q, and Proxy Statements.</span></li> <li style="font-size: 12pt;"><span style="font-size: 12pt;">Big Four public accounting experience required.</span></li> <li style="font-size: 12pt;"><span style="font-size: 12pt;">Experience preparing technical accounting memoranda and accounting position papers.</span></li> </ul> <p><span style="font-size: 12pt;"><strong>Preferred Qualifications</strong></span></p> <ul> <li style="font-size: 12pt;"><span style="font-size: 12pt;">Life sciences, biotechnology, pharmaceutical, or healthcare industry experience.</span></li> <li style="font-size: 12pt;"><span style="font-size: 12pt;">Experience with equity accounting, stock compensation, and SEC disclosure requirements.</span></li> <li style="font-size: 12pt;"><span style="font-size: 12pt;">Experience with implementation of SEC reporting software and or ERP system</span></li> <li style="font-size: 12pt;"><span style="font-size: 12pt;">Prior experience supporting SOX compliance and internal controls over financial reporting.</span></li> </ul><div class="content-pay-transparency"><div class="pay-input"><div class="title">Salary Range</div><div class="pay-range"><span>$100,000</span><span class="divider">&mdash;</span><span>$150,000 USD</span></div></div></div><div class="content-conclusion"><p><span style="font-size: 12pt;"><strong>*<span data-teams="true">Please note that Tonix does not offer sponsorship for this role.</span></strong></span></p> <p><span style="font-size: 12pt;"><strong>Recruitment &amp; Staffing Agencies</strong></span></p> <p><span style="font-size: 12pt;">Tonix does not accept agency resumes unless contacted directly by internal Tonix Talent Acquisition. Please do not forward resumes to Tonix employees or any other company location; Tonix is not responsible for any fees related to unsolicited resumes.</span></p> <p><span style="font-size: 12pt;"><strong>Compensation &amp; Benefits</strong></span></p> <p><span style="font-size: 12pt;">Tonix provides a comprehensive compensation and benefits package which includes:</span></p> <ul type="disc"> <li style="font-size: 12pt;"><span style="font-size: 12pt;">Medical, Dental &amp; Vision Insurance, Basic and Voluntary Life and AD&amp;D Insurance, Short- and Long-Term Disability Insurance, Flexible Spending Accounts, Health Savings Account, and Employee Assistance Programs</span></li> <li style="font-size: 12pt;"><span style="font-size: 12pt;">Pet Insurance</span></li> <li style="font-size: 12pt;"><span style="font-size: 12pt;">Retirement Savings 401k with company match and annual discretionary stock options</span></li> <li style="font-size: 12pt;"><span style="font-size: 12pt;">Generous Paid Time Off, Sick Time, &amp; Paid Holidays</span></li> <li style="font-size: 12pt;"><span style="font-size: 12pt;">Career Development and Training</span></li> </ul> <p><span style="font-size: 12pt;">Tonix provides equal employment opportunities (EEO) to all employees and applicants for employment without regard to race, color, religion, sex, national origin, age, genetics, or any other characteristic protected by law. &nbsp;In addition to federal law requirements, Tonix complies with applicable state and local laws governing nondiscrimination in employment. &nbsp;This policy applies to all terms and conditions of employment, including recruiting, hiring, placement, promotion, termination, layoff, recall, transfers, leaves of absence, compensation, and training. &nbsp;Tonix expressly prohibits any form of workplace harassment based on race, color, religion, gender, sexual orientation, gender identity or expression, national origin, age, genetic, information, disability, veteran status, or any other characteristic protected by law.</span></p></div>